Journal article

VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death

D Lambrechts, E Storkebaum, M Morimoto, J Del-Favero, F Desmet, SL Marklund, S Wyns, V Thijs, J Andersson, I Van Marion, A Al-Chalabi, S Bornes, R Musson, V Hansen, L Beckman, R Adolfsson, HS Pall, H Prats, S Vermeire, P Rutgeerts Show all

Nature Genetics | Published : 2003

Abstract

Amyotrophic lateral sclerosis (ALS) is an incurable degenerative disorder of motoneurons. We recently reported that reduced expression of Vegfa causes ALS-like motoneuron degeneration in Vegfa∂/∂ mice. In a meta-analysis of over 900 individuals from Sweden and over 1,000 individuals from Belgium and England, we now report that subjects homozygous with respect to the haplotypes -2,578A/-1,154A/-634G or -2,578A/-1,154G/-634G in the VEGF promoter/leader sequence had a 1.8 times greater risk of ALS (P = 0.00004). These 'at-risk' haplotypes lowered circulating VEGF levels in vivo and reduced VEGF gene transcription, IRES-mediated VEGF expression and translation of a novel large-VEGF isoform (L-VE..

View full abstract

University of Melbourne Researchers